U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07810985) titled 'Bismuth Quadruple Therapy Versus Modified Bismuth Therapy for Helicobacter Pylori' on Sept. 02.
Brief Summary: The primary objective of the study is to compare the efficacy of 2 different regimens of treatment of gastric bacteria (H pylori) these are: quadruple bismuth therapy and clarithromycin triple therapy with add-on bismuth, in eradicating H. pylori.
The secondary objective of the study is detection of adverse effects and treatment compliance in both regimens.
Study Start Date: Sept. 01, 2023
Study Type: INTERVENTIONAL
Condition:
Eradication of Helicobacter Pylori
Intervention:
DRUG: Bismuth added on triple therapy
A ...